Chemotherapy resumption in breast cancer patient after COVID-19

BACKGROUND: While many studies have verified the effect of recent anti-cancer treatment in patients with COVID-19, there are no data on the optimal time for cancer treatment resumption, as well as the safety of chemotherapy in COVID-19 patients. As many cancer patients are recovering from COVID-19,...

Descripción completa

Detalles Bibliográficos
Autores principales: Horiguchi, Julian, Nakashoji, Ayako, Kawahara, Naoki, Matsui, Akira, Kinoshita, Takayuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8294251/
https://www.ncbi.nlm.nih.gov/pubmed/34287742
http://dx.doi.org/10.1186/s40792-021-01253-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8294251/
https://www.ncbi.nlm.nih.gov/pubmed/34287742
http://dx.doi.org/10.1186/s40792-021-01253-0

Ejemplares similares